VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Jul 15, 2024 7:11pm

97 Views

Post# 36133799

Our 3rd Annual Echo in Pediatric and Congenital Heart Diseas

Interesting

American Society of Echocardiography

Our 3rd Annual Echo in Pediatric and Congenital Heart Disease is a two-day virtual course, presenting the latest information on established and emerging cardiovascular ultrasound technologies, clinical care and practical considerationsin children and adults with CHD. Sign up: bit.ly/3yR7NXg

Course Chairs:
Melissa Wasserman, RDCS, RCCS, FASE
Shiraz Maskatia, MD, FASE